Correlation Between Moderna and WUXI BIOLOGICS

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Moderna and WUXI BIOLOGICS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Moderna and WUXI BIOLOGICS into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Moderna and WUXI BIOLOGICS UNSPADR2, you can compare the effects of market volatilities on Moderna and WUXI BIOLOGICS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Moderna with a short position of WUXI BIOLOGICS. Check out your portfolio center. Please also check ongoing floating volatility patterns of Moderna and WUXI BIOLOGICS.

Diversification Opportunities for Moderna and WUXI BIOLOGICS

-0.11
  Correlation Coefficient

Good diversification

The 3 months correlation between Moderna and WUXI is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Moderna and WUXI BIOLOGICS UNSPADR2 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on WUXI BIOLOGICS UNSPADR2 and Moderna is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Moderna are associated (or correlated) with WUXI BIOLOGICS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of WUXI BIOLOGICS UNSPADR2 has no effect on the direction of Moderna i.e., Moderna and WUXI BIOLOGICS go up and down completely randomly.

Pair Corralation between Moderna and WUXI BIOLOGICS

Assuming the 90 days horizon Moderna is expected to under-perform the WUXI BIOLOGICS. But the stock apears to be less risky and, when comparing its historical volatility, Moderna is 1.33 times less risky than WUXI BIOLOGICS. The stock trades about -0.01 of its potential returns per unit of risk. The WUXI BIOLOGICS UNSPADR2 is currently generating about 0.25 of returns per unit of risk over similar time horizon. If you would invest  338.00  in WUXI BIOLOGICS UNSPADR2 on September 23, 2024 and sell it today you would earn a total of  80.00  from holding WUXI BIOLOGICS UNSPADR2 or generate 23.67% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Moderna  vs.  WUXI BIOLOGICS UNSPADR2

 Performance 
       Timeline  
Moderna 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Moderna has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
WUXI BIOLOGICS UNSPADR2 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in WUXI BIOLOGICS UNSPADR2 are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, WUXI BIOLOGICS reported solid returns over the last few months and may actually be approaching a breakup point.

Moderna and WUXI BIOLOGICS Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Moderna and WUXI BIOLOGICS

The main advantage of trading using opposite Moderna and WUXI BIOLOGICS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Moderna position performs unexpectedly, WUXI BIOLOGICS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in WUXI BIOLOGICS will offset losses from the drop in WUXI BIOLOGICS's long position.
The idea behind Moderna and WUXI BIOLOGICS UNSPADR2 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Fundamental Analysis
View fundamental data based on most recent published financial statements
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators